Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05024318
Title NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia

renal cell carcinoma



Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from for the field